Dr Harriet Teare
Deputy Director, HeLEX
Dr Harriet Teare’s research interests relate to the role of participants in medical research, and improving governance infrastructure to support communication and interactive engagement. She contributes to a number of specific research projects, including providing research governance and ethical support to the DIRECT project – an IMI-JU funded collaboration exploring stratification in Type 2 diabetes, the Rudy project – a research network for rare diseases of the blood, bone and joints, and leads a work package focusing on consent in the Genetics Clinic of the Future – a Horizon 2020 project mapping the complex challenges that will need to be tackled to introduce genome sequencing more widely into the clinic. Harriet obtained a DPhil in Chemistry from Merton College, Oxford, and previously worked as a senior policy advisor at Cancer Research UK, focusing on policy issues relating to science and research, and public health.
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
Koivula RW. et al, (2019), Diabetologia, 62, 1601 - 1615
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.
Wilman HR. et al, (2019), J Hepatol, 71, 594 - 602
Consent for Data Processing under the General Data Protection Regulation: Could 'Dynamic Consent' be a Useful Tool for Researchers?
KAYE J. et al, (2019), Journal of Data Protection and Privacy
Motivations for data sharing-views of research participants from four European countries: A DIRECT study.
Shah N. et al, (2019), Eur J Hum Genet
Wider research applications of dynamic consent
Schuler Scott A. et al, (2019), IFIP Advances in Information and Communication Technology, 547, 114 - 120